Entcho Klenske

Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion

David Simón, Koray Taşçılar, Gerhard Krönke et al. · Nature Communications · 2020 · 87 citations · Full text

Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn’s Disease

Entcho Klenske, Lourdes Osaba, Daniel Nagore et al. · Journal of Crohn s and Colitis · 2018 · 60 citations · Full text

Therapy-refractory Crohn, Gastrointestinal Pharmacology, Medicine +12

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease

Charlotte Lichnog, Sha Klabunde, Emily Becker et al. · Frontiers in Pharmacology · 2019 · 34 citations · Full text

Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study

Clarissa Allner, Michaela Melde, Emily Becker et al. · BMC Gastroenterology · 2020 · 24 citations · Full text

Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab

Sarah Fischer, Sarah Cohnen, Entcho Klenske et al. · Therapeutic Advances in Gastroenterology · 2021 · 23 citations · Full text